Wall Street Journal -- News from this week’s gathering of the American Society of Clinical Oncology in Chicago, the world’s largest annual cancer meeting, underscores how good we have become at turning new scientific principles into superior medicines. For those who gripe that progress from our huge investments in cancer research is too little or too slow, stunning results from two experimental drugs tell a different story.
